In 1987 was created Oxford University Innovation, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Oxford. The company was established in Europe in United Kingdom.
Among the most popular fund investment industries, there are Medical, Information Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Genomics, Oxford MEStar, GYANA.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Oxford University Innovation, startups are often financed by Oxford Sciences Innovation, Parkwalk Advisors, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Parkwalk Advisors, Oxford Investment Consultants LLP, IP Group Plc. In the next rounds fund is usually obtained by Oxford Sciences Innovation, Innovate UK, IP Group Plc.
The overall number of key employees were 10.
This Oxford University Innovation works on 23 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 7 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Oxford University Innovation is 10-50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2018.
|70Ventures||Lithuania, Vilniaus Apskritis, Vilnius|
|Caitong Capital||China, Hangzhou, Zhejiang|
|Dalewood Associates||New York, New York, United States|
|Eatable Adventures||Community of Madrid, Madrid, Spain|
|Garnett & Helfrich Capital||California, San Mateo, United States|
|Globo||California, Palo Alto, United States|
|Idanta Partners||California, San Diego, United States|
|IntelleGrow||India, Maharashtra, Mumbai|
|Maliang Capital||China, Futian, Guangdong|
|MAR ventures||Brazil, São Paulo, Sao Paulo|
|Quan Capital||China, Shanghai|
|SARR||Japan, Kyoto, Kyoto Prefecture|
|Shanghai Bingye Qiye Guanlizhongxin||China, Shanghai|
|Shinkin Capital||Japan, Tokyo|
|University Medical Center Groningen||Groningen, Groningen, The Netherlands|
|Utrust.cn||China, Guangdong, Guangzhou|
|Xinzhi Touzi||China, Jiangsu, Taizhou|
|$21M||16 Dec 2021||Oxford, England, United Kingdom|
|$2M||05 May 2021||Oxford, England, United Kingdom|
|$13M||12 Feb 2020||United Kingdom, England|
|$1M||19 Jul 2019||United Kingdom, England|
|$1M||15 Jul 2019||Oxford, England, United Kingdom|
|$47M||02 Sep 2018||Oxford, England, United Kingdom|
|28 Aug 2018||Oxford, England, United Kingdom|
|$3M||11 Jun 2018||United Kingdom, London|
|$9M||23 May 2018||Oxford, England, United Kingdom|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.